These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 9685708)

  • 1. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
    Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
    Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and repair in somatic and germ cells in vivo.
    Vogel EW; Natarajan AT
    Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules.
    Vogel EW; Nivard MJ
    Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative procedures for health risk assessment.
    Lohman PH
    Mutat Res; 1999 Jul; 428(1-2):237-54. PubMed ID: 10517997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic effects of inhaled ethylene oxide, propylene oxide and butylene oxide on germ cells: sensitivity of genetic endpoints in relation to dose and repair status.
    Vogel EW; Nivard MJ
    Mutat Res; 1998 Sep; 405(2):259-71. PubMed ID: 9748619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative comparative mutagenesis in bacteria, mammalian cells, and animal-mediated assays. A convenient way of estimating genotoxic activity in vivo?
    Mohn GR; van Zeeland AA
    Mutat Res; 1985; 150(1-2):159-75. PubMed ID: 3889614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic activity profiles of anticancer drugs.
    Jackson MA; Stack HF; Waters MD
    Mutat Res; 1996 Aug; 355(1-2):171-208. PubMed ID: 8781583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine.
    Wijen JP; Nivard MJ; Vogel EW
    Carcinogenesis; 2000 Oct; 21(10):1859-67. PubMed ID: 11023544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.